This 2018 review underscores the pivotal role of coronary artery calcium (CAC) scoring in the primary prevention of coronary artery disease (CAD). CAC scoring, obtained through non-contrast CT scans, provides a direct measure of atherosclerotic plaque burden, offering superior risk stratification compared to traditional risk assessment tools. The article highlights
The 2020 ROBINSCA trial, a randomized controlled population-based study in the Netherlands, evaluated the effectiveness of coronary artery calcium (CAC) scoring versus traditional risk factor assessment (SCORE model) for cardiovascular disease (CVD) screening in asymptomatic adults. Participants were randomized into three groups: control (usual care), SCORE-based screening, and CAC-based screening.
This 2017 review article discusses the significance of coronary artery calcium (CAC) scoring in cardiovascular risk assessment. Elevated CAC scores indicate advanced atherosclerosis and a higher risk for cardiovascular disease (CVD), warranting conventional therapies such as aspirin, statins, and lifestyle modifications. The 2013 ACC/AHA guidelines recommend intensified statin therapy for
This 2019 review provides an in-depth examination of coronary artery calcium (CAC) scoring using computed tomography (CT) as a non-invasive method to assess coronary atherosclerosis and guide cardiovascular risk stratification. The article details the technical aspects of performing CAC scans, including acquisition protocols and calculation of the Agatston score. It
